Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,250 | 69 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,156 | 25 | $0 (2024) |
| GENZYME CORPORATION | $774.06 | 6 | $0 (2024) |
| Amgen Inc. | $433.23 | 9 | $0 (2024) |
| Lilly USA, LLC | $372.55 | 14 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $191.88 | 6 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $123.76 | 1 | $0 (2023) |
| LEO Pharma Inc. | $87.49 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $48.97 | 3 | $0 (2023) |
| Incyte Corporation | $24.43 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $20.59 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $354.72 | 12 | GENZYME CORPORATION ($147.56) |
| 2023 | $846.74 | 16 | Lilly USA, LLC ($171.06) |
| 2022 | $785.22 | 13 | ABBVIE INC. ($476.10) |
| 2021 | $1,016 | 18 | AbbVie Inc. ($409.85) |
| 2020 | $247.25 | 10 | Amgen Inc. ($140.73) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.35 | General |
| Category: Immunology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.44 | General |
| Category: Immunology | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.11 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.95 | General |
| Category: Immunology | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.25 | General |
| Category: Immunology | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Inflammation | ||||||
| 06/28/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Dermatology | ||||||
| 04/16/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Inflammation | ||||||
| 03/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $147.56 | General |
| Category: Immunology | ||||||
| 10/18/2023 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $123.76 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/18/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: Immunology | ||||||
| 06/23/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Inflammation | ||||||
| 06/16/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Immunology | ||||||
| 06/16/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: IMMUNOLOGY | ||||||
| 06/16/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $1.23 | General |
| Category: Immunology | ||||||
| 05/22/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $71.20 | General |
| Category: DERMATOLOGY | ||||||
| 05/06/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Immunology | ||||||
| 04/07/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: IMMUNOLOGY | ||||||
| 03/30/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $110.78 | General |
| Category: Immunology | ||||||
| 03/28/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: IMMUNOLOGY | ||||||
| 03/18/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $120.14 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2023 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | Cash or cash equivalent | $124.88 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 503 | 871 | $57,741 | $22,048 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 109 | 109 | $14,764 | $6,570 | 44.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $12,331 | $5,921 | 48.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 99 | 102 | $6,018 | $3,748 | 62.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 72 | 73 | $9,271 | $1,375 | 14.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 23 | 24 | $3,552 | $1,148 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 14 | $2,184 | $1,022 | 46.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 20 | $2,200 | $988.40 | 44.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 78 | 430 | $4,730 | $650.68 | 13.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 28 | 39 | $2,691 | $625.89 | 23.3% |
About Dr. Christopher Dallo, MD
Dr. Christopher Dallo, MD is a Dermatology healthcare provider based in Cedar Park, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2019. The National Provider Identifier (NPI) number assigned to this provider is 1063071199.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Dallo, MD has received a total of $3,250 in payments from pharmaceutical and medical device companies, with $354.72 received in 2024. These payments were reported across 69 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($3,250).
As a Medicare-enrolled provider, Dallo has provided services to 503 Medicare beneficiaries, totaling 871 services with total Medicare billing of $22,048. Data is available for 1 year (2023–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Cedar Park, TX
- Active Since 06/12/2019
- Last Updated 10/07/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1063071199
Products in Payments
- SKYRIZI (Biological) $627.50
- DUPIXENT (Biological) $568.55
- Otezla (Drug) $433.23
- RINVOQ (Biological) $201.31
- Sotyktu (Drug) $191.88
- TALTZ (Drug) $164.09
- BOTOX (Biological) $126.12
- OLUMIANT (Drug) $124.88
- ADBRY (Biological) $71.20
- HUMIRA (Biological) $58.55
- TREMFYA (Drug) $48.97
- OPZELURA (Drug) $24.43
- COSENTYX (Drug) $20.59
- EUCRISA (Drug) $16.91
- ENSTILAR (Drug) $16.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Cedar Park
Aubrey Hartmann, Md, MD
Dermatology — Payments: $164,879
Dr. Hubert Chodkiewicz, M.d, M.D
Dermatology — Payments: $12,630
Dr. Donna Hart, M.d, M.D
Dermatology — Payments: $11,413
Jessica Dorsey, Md, MD
Dermatology — Payments: $10,153
Shwol-Huo Kiang, Do, DO
Dermatology — Payments: $3,011
Lori Honeycutt, M.d, M.D
Dermatology — Payments: $2,679